全球黄热病疫苗短缺

2016-04-07 赵熙熙 中国科学报

安哥拉军队在今年2月于罗安达为居民接种黄热病疫苗。 图片来源:JOOST DE RAEYMAEKER 3个穿着淡蓝色塑料套装、戴着护目镜的人形成了一个人类鸡胚“传送带”。其中第一个人向鸡蛋中注入一种黄热病疫苗病毒,然后孵化4天,之后再将蛋壳顶部削掉;第二个人用镊子取出胚胎并放入一个大瓶子中;第三个人则向瓶中添加一些液体,随后再将这些胚胎混合成为包含数以百万减弱病毒颗粒的红汤。

安哥拉军队在今年2月于罗安达为居民接种黄热病疫苗。

图片来源:JOOST DE RAEYMAEKER

3个穿着淡蓝色塑料套装、戴着护目镜的人形成了一个人类鸡胚“传送带”。其中第一个人向鸡蛋中注入一种黄热病疫苗病毒,然后孵化4天,之后再将蛋壳顶部削掉;第二个人用镊子取出胚胎并放入一个大瓶子中;第三个人则向瓶中添加一些液体,随后再将这些胚胎混合成为包含数以百万减弱病毒颗粒的红汤。

这个过程的最终结果是一种高度有效的疫苗,能够对黄热病提供终身保护,在塞内加尔达喀尔的巴斯德研究所每周都会重复几十次这样的过程。然而这种有80年历史的过程显然技术含量较低并且难以大规模推广,而这也带来了一个新问题——于2015年12月在安哥拉首都罗安达暴发的黄热病疫情已经耗尽了这种疫苗的全球战略储备。

每年生产约1000万支疫苗的巴斯德研究所是全球能够生产黄热病疫苗的4家机构之一,另外3家分别是俄罗斯和巴西的两家官办工厂以及法国疫苗公司赛诺菲巴斯德。它们的总产量一直未能满足全球需求,而安哥拉暴发的黄热病疫情则加剧了这种短缺。

黄热病疫苗是对抗这种传染病的唯一堡垒。黄热病主要通过埃及伊蚊,也被称为黄热病蚊子的叮咬传播。大多数感染者没有任何症状,但有些人会出现发烧、关节痛和头痛等症状。其中约15%的人会发展到一个更严重的阶段,他们的眼睛和皮肤会变黄,甚至可能从眼睛、鼻子和口中流血。多达半数的严重病例是致命的。尽管黄热病主要流行于拉丁美洲,但如今非洲面临的形势却最为严峻。

虽然准确数字难以获得,但《科学公共图书馆—医学》杂志2014年发表的一项研究估计,这种传染病每年会导致78000名非洲人死亡——尽管许多专家认为这一数字可能被高估了。

世界卫生组织4月4日发表公报称,自去年年底以来,安哥拉黄热病疫情已造成198人死亡。随着疫情在该国扩散,非洲其他国家和中国均发现了输入性病例,全球处于黄热病疫苗紧缺状态。

世卫组织表示,安哥拉自2015年12月起暴发黄热病疫情,目前感染人数超过490人,其中198人不治身亡,疫情传播范围已从首都罗安达扩散至该国三分之一的省份。

世卫组织总干事陈冯富珍4日开始在罗安达评估疫情并考察疫苗接种项目。她表示:“这是30年来安哥拉面临的最严峻的黄热病疫情,世卫组织正开展紧急行动,通过大范围疫苗接种帮助该国政府控制疫情。”

世卫组织指出,疫苗接种是预防黄热病的最重要方法,99%的接种者在注射疫苗30天内即可获得有效免疫力。

截至3月末,世卫组织及其合作伙伴总共为罗安达地区的570万人口接种了黄热病疫苗。这些疫苗来自世卫组织参与的“国际协调小组”的应急储备,但目前已经耗尽。世卫组织表示,安哥拉仅罗安达省就需要额外150万剂疫苗,为高风险人群接种。目前,该组织正与疫苗生产方及合作伙伴讨论,可否将一些国家用于常规免疫计划的疫苗转拨给上述“国际协调小组”。

据新华社报道,中国国家卫生计生委通报显示,自今年3月以来,北京、上海、福建等地报告发现数例来自安哥拉的输入性黄热病确诊病例。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-10-06 1e10c84am36(暂无匿称)

    文章真心很好,感谢作者

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-10-06 1e10c84am36(暂无匿称)

    文章真心很好,感谢作者

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-07-10 oo902

    黄热病疫苗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-04-14 李继凯

    国家要加大投入啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-04-14 李继凯

    dd值得关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-04-09 liuxiaona
  7. [GetPortalCommentsPageByObjectIdResponse(id=141034, encodeId=7cbe14103456, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:01:45 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=141024, encodeId=6bef141024af, content=文章真心很好,感谢作者, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Thu Oct 06 14:00:07 CST 2016, time=2016-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92629, encodeId=522292629f0, content=黄热病疫苗, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 10 19:53:00 CST 2016, time=2016-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78331, encodeId=63c2e8331df, content=国家要加大投入啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78332, encodeId=a0ebe8332f6, content=dd值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 19:01:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628064, encodeId=230016280641c, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Sat Apr 09 00:17:00 CST 2016, time=2016-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=76251, encodeId=89f6e6251d9, content=疫苗接种,也是预防疾病的一种方法。, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160313/IMG56E50DEC424F44672.jpg, createdBy=ce5b1699635, createdName=Lisa971, createdTime=Thu Apr 07 12:51:00 CST 2016, time=2016-04-07, status=1, ipAttribution=)]
    2016-04-07 Lisa971

    疫苗接种,也是预防疾病的一种方法。

    0

相关资讯

世卫组织表示全球黄热病疫苗紧缺

世界卫生组织4日发表公报称,自去年年底以来,安哥拉黄热病疫情已造成198人死亡。随着疫情在该国扩散,非洲其他国家和中国发现输入性病例,全球处于黄热病疫苗紧缺状态。 世卫组织表示,安哥拉自2015年12月起暴发黄热病疫情,目前感染人数超过490人,其中198人不治身亡,疫情传播范围已从首都罗安达扩散至该国三分之一的省份。 世卫组织总干事陈冯富珍4日开始在罗安达评估疫情并考察疫苗接种项目。

上海确诊一例境外输入性黄热病例

3月18日,上海市卫生计生委通报1例境外输入性外来就诊黄热病确诊病例。患者,男,46岁,江苏省人,劳务输出至安哥拉首都罗安达工作,3月7日晚21时抵沪,入境时体温正常,3月17日中国疾控中心报告黄热病毒核酸检测结果阳性。黄热病可防可控,相关问答见图。     

中国发现首例输入性黄热病病例

根据国家卫计委官方网站昨日(13日)通报,国家卫计委组织专家确诊一例输入性黄热病病例。该病例于3月10日凌晨2时抵达北京,直接主动到医院就诊。 患者从安哥拉回京 据悉,患者为男性,32岁,浙江省人,常年在安哥拉首都罗安达(近期发生黄热病疫情)做生意。患者于3月8日(北京时间)在罗安达出现发热,体温最高39.3℃,伴畏寒等症状,于3月9日乘飞机经迪拜转机,3月10日凌晨2时抵达北京,直接主动

官方要求加强入境人员医学巡查 防苏丹黄热病传入

  根据世界卫生组织(WHO)11月14日报告,苏丹爆发黄热病疫情,截至11月11 日共发现329例黄热病疑似病例,其中死亡97例。据国家质检总局网站消息,国家质检总局日前发布公告,要求采取措施防止苏丹黄热病传入中国。   公告强调,出入境检验检疫机构应当加强对来自苏丹流行区人员的体温检测、医学巡查等工作,对主动申报的或现场发现的黄热病染疫人和染疫嫌疑人,出入境检验检疫机构应当按规定程序采取隔离

北京已确诊4例输入性黄热病病例

北京市卫生计生委今日(3月21日)通报,昨天新确诊1例输入性黄热病病例,这是继3月13日北京发现中国首例输入性黄热病病例后,确诊的第4例病例。 据通报,患者张某,男,50岁,福建省三明市人,安哥拉务工人员,出国前未接种黄热病疫苗。患者于3月6日(北京时间)在安哥拉出现发热、全身不适等症状,3月6日至16日前往当地多家医院诊治,3月18日乘飞机经迪拜转机,3月18日晚抵达北京首都机场,入境时体温正